TRYNISKI MARK E 4

Accession 0001127602-21-028634

CIK 0000816956other

View on SEC.gov Company Profile

Filed

Nov 7, 7:00 PM ET

Accepted

Nov 8, 8:59 PM ET

Size

31.2 KB

Accession

0001127602-21-028634

Insider Transaction Report

Form 4

Period: 2021-11-05

CONMED CorpCNMD

TRYNISKI MARK E

Director

Transactions

Sale
Common Stock
2021-11-05$156.95/sh−500$78,475→ 8,296 total
Sale
Common Stock
2021-11-05$156.48/sh−1,743$272,750→ 8,396 total
Sale
Common Stock
2021-11-05$157.11/sh−100$15,711→ 8,296 total
Sale
Common Stock
2021-11-05$156.51/sh−4,792$749,986→ 8,396 total
Exercise/Conversion
Common Stock
2021-11-05$69.03/sh+3,399$234,633→ 11,695 total
Exercise/Conversion
Common Stock
2021-11-05$79.94/sh+2,886$230,707→ 11,182 total
Sale
Common Stock
2021-11-05$157.05/sh−100$15,705→ 8,296 total
Exercise/Conversion
Options To Purchase Common Stock
2021-11-05−4,892→ 0 total
Exercise: $51.90From: 2018-06-01Exp: 2027-06-01→ Common Stock (4,892 underlying)
Exercise/Conversion
Options To Purchase Common Stock
2021-11-05−2,886→ 0 total
Exercise: $79.94From: 2020-06-01Exp: 2029-06-03→ Common Stock (2,886 underlying)
Exercise/Conversion
Options To Purchase Common Stock
2021-11-05−3,399→ 0 total
Exercise: $69.03From: 2019-06-01Exp: 2028-06-01→ Common Stock (3,399 underlying)
Exercise/Conversion
Options To Purchase Common Stock
2021-11-05−1,843→ 0 total
Exercise: $73.94From: 2021-06-01Exp: 2030-06-01→ Common Stock (1,843 underlying)
Exercise/Conversion
Common Stock
2021-11-05$51.90/sh+4,892$253,895→ 13,188 total
Sale
Common Stock
2021-11-05$156.44/sh−2,386$373,256→ 8,796 total
Sale
Common Stock
2021-11-05$156.44/sh−2,899$453,517→ 8,796 total
Sale
Common Stock
2021-11-05$157.06/sh−500$78,531→ 8,296 total
Exercise/Conversion
Common Stock
2021-11-05$73.94/sh+1,843$136,271→ 10,139 total

Footnotes (8)

[F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.01 to $156.96. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
[F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.82 to $156.81. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
[F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.83 to $157.37. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
[F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.81 to $156.76. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
[F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.86 to $157.12. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
[F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.01 to $156.96. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
[F7]The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.
[F8]The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

CONMED Corp

CIK 0000816956

→

Entity typeother

Related Parties

filerCIK 0001242753

Filing Metadata

Form type: 4
Filed: Nov 7, 7:00 PM ET
Accepted: Nov 8, 8:59 PM ET
Size: 31.2 KB

View on SEC.gov